4//SEC Filing
Feldmann Marc 4
Accession 0001213900-23-096503
CIK 0001690080other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:15 PM ET
Size
5.1 KB
Accession
0001213900-23-096503
Insider Transaction Report
Form 4
Feldmann Marc
Director10% Owner
Transactions
- Sale
Common Stock
2023-12-15$0.19/sh−25,000$4,700→ 115,497 total
Footnotes (1)
- [F1]Effective on December 15, 2023, Prof. Sir Marc Feldmann, the Co-Executive Chairman of the Issuer, sold 25,000 shares of common stock of the Issuer to Dr. James N. Woody, the Chief Executive Officer of the Issuer, in a private transaction, for $4,720 or $0.188 per share, the closing sales price of the Issuer's common stock on such effective date.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001832327
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 4:15 PM ET
- Size
- 5.1 KB